Molecular "tweezers" pick apart bacterias' biofilm

By plucking out peptides, the tweezers can destroy the drug and immune system blocking shield.

An incredibly tiny version of your grooming tool may become a new weapon against bacteria. Alongside German and American partners, researchers at Israel’s Ben-Gurion University (BGU) have developed a set of “molecular tweezers” that take aim at the biofilm that protects bacteria, The Jerusalem Post reports.

“The success of the study in damaging biofilm using molecular tweezers indicates an innovative direction of antibiotic treatments against pathogenic bacteria without concerns of developing resistance,” Raz Jelinek, vice president and dean for research and development at BGU, told the Post.

Antimicrobial armor: A biofilm is formed when a group of cells form a protective barrier on a surface; in the case of bacteria, these biofilms can provide an effective shield from antibiotics, creating a unique, and sometimes dramatic, form of antimicrobial resistance — they don’t go down easy.

Biofilm bacteria have been found on all manner of medical implants, including “prosthetic heart valves, orthopedic implants, intravascular catheters, artificial hearts, left ventricular assist devices, cardiac pacemakers, vascular prostheses, cerebrospinal fluid shunts, urinary catheters, ocular prostheses and contact lenses, and intrauterine contraceptive devices.”

Once a biofilm-protected bacterial infection sets in, the consequences can be devastating, as the protected bacteria wreak havoc safely ensconced from antibiotics and our immune system.

A biofilm to pick: Biofilms are made, in part, by tiny fibers. It’s those little support structures that Jelinek, the study lead, and student Ravit Malishev took aim at.

“The tweezers are just like your home tweezers but a million times smaller, and instead of plucking hairs they attack fibers of the bacteria’s biofilm,” Jelinek told Americans for Ben-Gurion University, relayed by EurekAlert!

In their study, published in Cell Chemical Biology, the researchers turned the tweezers loose on Staphylococcus aureus, the notorious bug behind Staph infections.

The tweezers impact a special peptide that Staph secretes that acts as a biofilm scaffolding, the researchers write. By inhibiting the peptide’s ability to form biofilms, the tweezers weaken and break the biofilm, allowing the immune system and/or antibiotics to take the fight to the Staph, proof-of-concept for molecular tweezers potentially becoming part of our infection-fighting arsenal.

“In fact, this is the first time it has been shown that biofilm formation can be prevented and existing biofilm destroyed by molecular tweezers,” Jelinek told The Jerusalem Post.

It took three years for the researchers to tease out how exactly the molecular tweezers were picking apart the biofilms, Malishev told the Post. 

Because the tweezers mechanically attack the biofilm, and not the bacteria itself, the method doesn’t lend itself to evolving resistance.

Getting from here to hospitals: It’s a haul from proof-of-concept against one bacteria — albeit it a common one, which causes lots of problems — and tearing biofilms apart like fashion police on the Met carpet. Jelinek envisions someday people being able to swallow the tiny tweezers, which will then find their way to the biofilm and get to work.

“This breakthrough may open up new ways to fight antibiotic-resistant bacteria,” Malishev said.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Related
Weight-loss drug reduces cravings for opioids in small study
A first-of-its-kind trial found that GLP-1 agonists, a popular kind of weight-loss drug, could help people overcome their opioid cravings.
The untapped potential of stem cells in menstrual blood
Stem cells found in menstrual blood could unlock new therapies and diagnostic tests, some researchers argue.
Evidence that gamma rhythm stimulation can treat neurological disorders is emerging
Researchers survey the therapeutic potential of noninvasive sensory, electrical, or magnetic stimulation of gamma brain rhythms.
New pharma supergroup aims to tackle skin disorders
Six biotech companies just merged to form Alys Pharmaceuticals with the goal of developing new treatments for skin disorders.
How to stop our immune systems from turning on us
From “inverse vaccines” to repurposed cancer therapies, several potential cures for autoimmune diseases are showing serious promise.
Up Next
gene therapy
Subscribe to Freethink for more great stories